Professor Rajiv Khanna
Professor Rajiv Khana leads the Tumour Immunology Laboratory at QIMR and is the director of the QIMR Berghofer Centre for Immunotherapy and Vaccine Development. He has developed innovative and successful research programs that are being applied to the treatment and/or prevention of human cancer, chronic infections and autoimmune conditions. He is an expert in EBV transformation of human PBMCs and is collaborating with Professors Vinuesa and Cook to establish cell lines from SLE and CVID affected individuals. DNA editing of these cell lines will prove that the mutated variants cause the cellular phenotypes observed in patients.